Lung, Phase I-II

Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this trial is to test a deescalated 3-fraction stereotactic body radiotherapy (SBRT) regimen to 45 Gray (Gy) in 3 fractions for centrally located thoracic tumors.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Katie Wildman

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Henry S. Park, MD, MPH
Professor of Therapeutic Radiology; Vice Chair for Clinical Research, Health Services Research, and Faculty Development, Therapeutic Radiology; Chief, Thoracic Radiotherapy Program, Therapeutic Radiology; Chief, PET-Guided Radiotherapy Program, Therapeutic Radiology; Assistant Medical Director, Clinical Trials Office, Yale Cancer Center; Head of Advisory House, Horstmann House, Office of Student Affairs

Sub-Investigators

Last Updated
10/12/2025
Study HIC
#2000025868